These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 24779560

  • 1. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM, Farid RM, Kassem AA.
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
    Shah H, Nair AB, Shah J, Bharadia P, Al-Dhubiab BE.
    Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
    Zidan AS, Mokhtar M.
    J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA.
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK.
    J Control Release; 2007 Nov 06; 123(2):148-54. PubMed ID: 17884226
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM.
    Eur J Pharm Biopharm; 2005 Apr 06; 59(3):485-90. PubMed ID: 15760729
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V, Praveen C, Prasanth KG, Srinivas CR, Ruckmann K.
    Pharmazie; 2009 Nov 06; 64(11):731-4. PubMed ID: 20099517
    [Abstract] [Full Text] [Related]

  • 15. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
    Ramkanth S, Chetty CM, Sudhakar Y.
    Pak J Pharm Sci; 2014 Jan 06; 27(1):115-20. PubMed ID: 24374439
    [Abstract] [Full Text] [Related]

  • 16. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V, Gupta S, Saini V.
    Drug Deliv; 2016 Nov 06; 23(9):3573-3581. PubMed ID: 27494650
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S, Jain NK, Bedi PM.
    Life Sci; 2013 Nov 13; 93(21):763-72. PubMed ID: 24113071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.